JPRN-jRCT1080220157未知4 期
Post-marketing clinical trial of Pegasys 180ug for subcutaneous injection (s.c.) in patients with chronic hepatitis C. -General clinical study in IFN-treated or IFN-untreated chronic hepatitis C patients, except for those infected with genotype 1b of hepatitis C virus and a high viral load.
适应症
试验速览
- 阶段
- 4 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Over 20 years old of male and female patients with chronic hepatitis C except for those infected with genotype 1b and a high viral load (>= 100 KIU/mL).And the patient shows positive serum HCV-RNA, and increase of serum ALT above the normal upper limit of the site.
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Trial of Pegasys® in Patients With Chronic Hepatitis CChronic Hepatitis CNCT00245414Chugai Pharmaceutical108
进行中（未招募）
1 期
Peg-IFN, RBV and telaprevir vs Peg-IFN and RBV alone in patients with acute hepatitis C and HIV co-infectioAcute hepatitis C infectionEUCTR2012-005525-75-GBSt Stephen's AIDS Trust24
已完成
不适用
Continuous administration trial of PEGASUS-PC Study (Phase2/3 study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer)nresectable Advanced and Recurrent Pancreatic CancerJPRN-UMIN000005133OncoTherapy Science, Inc.7
尚未招募
3 期
Study of Pegylated interferon alfa-2a in combination with Lamivudine or Entecavir in children with Chronic Hepatitis BCTRI/2017/07/009027F HoffmannLa Roche Ltd114
已完成
4 期
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infectionHepatitis C, ChronicNCT00353418Hoffmann-La Roche415